Inventia Healthcare Pvt Ltd
General
Total Cases3
Active Cases3
Patents7
Ratings
Experience
Grade
Trend
DCT
--
--
--
PTAB
--
--
--
CAFC
--
--
--
Analytics
Cases
Litigated Patents
Ratings Trends
Recent Dockets
Entered | Case | Description |
---|---|---|
09/17/24 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024) | |
09/17/24 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024) | |
09/17/24 | Amended Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Platinum Equity for Inventia Healthcare Limited filed by Inventia Healthcare Limited. (Dorsney, Kenneth) (Entered: 09/17/2024) | |
07/11/24 | [SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
07/11/24 | [SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
07/11/24 | [SEALED] Joint STATUS REPORT - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
07/11/24 | [SEALED] Joint STIPULATION - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
07/11/24 | [SEALED] Joint STIPULATION - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
07/11/24 | [SEALED] Joint STIPULATION - by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 07/11/2024) | |
04/05/24 | REDACTED VERSION of (175 in 1:15-cv-00921-CFC, 194 in 1:15-cv-00362-CFC) Status Report by Vanda Pharmaceuticals Inc.. (Fahnestock, Derek) (Entered: 04/05/2024) |